ERS International Congress, Madrid 2019

Browse by day:
Saturday, 28.09.2019
Sunday, 29.09.2019
Monday, 30.09.2019
Tuesday, 01.10.2019
Wednesday, 02.10.2019

 

View the presentations you missed during Congress!

More than 1,000 webcasts and slide presentations, 1,900 e-posters and 4,200 abstracts from the International Congress in Madrid and are now available.

 

Citations should be made in the following way: Authors. Title. Eur Respir J 2019; 54: Suppl. 63, abstract number.


ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension

Clinical trials session
Chairs: K. Hostettler (Basel, Switzerland)
Aims: to present important clinical trials in respiratory medicine; to summarise key findings and discuss with the audience experts conclusions, to bring clinical trial’s abstracts into the clinical context. This session is led by a chair and two expert discussants who will facilitate the discussions and summarise key messages.
Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)
A. Guenther (Giessen, Germany), A. Prasse (Hannover, Germany), M. Kreuter (Heidelberg, Germany), P. Neuser (Marburg, Germany), K. Rabe (Grossharnsdorf, Germany), F. Bonella (Essen, Germany), R. Bonnet (Bad Berka, Germany), C. Grohe (Berlin, Germany), M. Held (Würzburg, Germany), H. Wilkens (Homburg, Germany), P. Hammerl (Immenhausen, Germany), D. Koschel (Dresden, Germany), S. Blaas (Regensburg, Germany), H. Wirtz (Leipzig, Germany), J. Ficker (Nürnberg, Germany), W. Neumeister (Koblenz, Germany), N. Schönfeld (Berlin, Germany), M. Claussen (Grossharnsdorf, Germany), N. Kneidinger (Munich, Germany), M. Frankenberger (Munich, Germany), S. Hummler (Heidelberg, Germany), N. Kahn (Heidelberg, Germany), S. Tello (Giessen, Germany), J. Freise (Hannover, Germany), T. Welte (Hannover, Germany), C. Schade-Brittinger (Marburg, Germany), J. Behr (Münich, Germany)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - Phase II trial of pirfenidone in patients with progressive fibrosing unclassifiable ILD (uILD)
T. Maher (London, United Kingdom), T. Corte (Camperdown, Australia), A. Fischer (Denver, United States of America), M. Kreuter (Heidelberg, Germany), D. Lederer (New York, United States of America), M. Molina-Molina (Barcelona, Spain), J. Axmann (Basel, Switzerland), K. Kirchgaessler (Basel, Switzerland), K. Samara (Maroussi, Greece), F. Gilberg (Basel, Switzerland), V. Cottin (Lyon, France)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Nintedanib in patients with chronic fibrosing interstitial lung diseases with progressive phenotype: the INBUILD trial
K. Flaherty (Ann Arbor, MI, United States of America), A. Wells (London, United Kingdom), V. Cottin (Lyon, France), A. Devaraj (London, United Kingdom), Y. Inoue (Osaka, Japan), L. Richeldi (Rome, Italy), S. Walsh (London, United Kingdom), S. Stowasser (Ingelheim am Rhein, Germany), C. Coeck (Brussels, Belgium), R. Goeldner (Biberach, Germany), E. Clerisme-Beaty (Ingelheim am Rhein, Germany), R. Schlenker-Herceg (Ridgefield, CT, United States of America), K. Brown (Denver, CO, United States of America)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Changes in FVC in the SENSCIS trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD)
K. Highland (Cleveland, Ohio, United States of America), A. Azuma (Tokyo, Japan), A. Fischer (Denver, Colorado, United States of America), M. Kuwana (Tokyo, Japan), T. Maher (London , United Kingdom), M. Mayes (Houston, Texas, United States of America), G. Raghu (Seattle, United States of America), M. Girard (Reims, France), M. Alves (Ingelheim am Rhein, Germany), M. Gahlemann (Basel , Switzerland), O. Distler (Zurich, Switzerland)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Lung function preservation in a phase 3 trial of tocilizumab (TCZ) in systemic sclerosis (SSc)
C. Denton (London, United Kingdom), C. Lin (South San Francisco, United States of America), J. Goldin (Los Angeles, United States of America), G. Kim (Los Angeles, United States of America), M. Kuwana (Tokyo, Japan), Y. Allanore (Paris, France), A. Batalov (Plovdiv, Bulgaria), I. Butrimiene (Vilnius, Lithuania), P. Carreira (Madrid, Spain), M. Matucci-Cerinic (Florence, Italy), O. Distler (Zurich, Switzerland), D. Martinovic Kaliterna (Split, Croatia), C. Mihai (Bucharest, Romania), M. Mogensen (Copenhagen, Denmark), M. Olesinska (Warsaw, Poland), J. Pope (London, Canada), G. Riemekasten (Berlin, Germany), T. Rodriguez-Reyne (Mexico City, Mexico), M. Santos (Almada, Portugal), J. Van Laar (Utrecht, Netherlands), H. Spotswood (Welwyn Garden City, United Kingdom), J. Siegel (South San Francisco, United States of America), A. Jahreis (South San Francisco, United States of America), D. Furst (Los Angeles, United States of America), D. Khanna (Ann Arbor, United States of America)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Late Breaking Abstract - Safety and efficacy of B-cell depletion with rituximab for the treatment of systemic sclerosis-associated pulmonary arterial hypertension.
R. Zamanian (Stanford, United States of America), D. Badesch (Denver, United States of America), L. Chung (Stanford, United States of America), R. Domsic (Pittsburg, United States of America), T. Medsger (Pittsburg, United States of America), A. Pinckney (Durham, United States of America), L. Keyes-Elstein (Durham, United States of America), C. D'Aveta (Durham, United States of America), M. Spychala (Durham, United States of America), J. White (Rochester, United States of America), P. Hassoun (Baltimore, United States of America), F. Torres (Dallas, United States of America), J. Molitor (Minneapolis, United States of America), D. Khanna (AnnArbor, United States of America), H. Maeker (Stanford, United States of America), B. Welch (Bethesda, United States of America), E. Goldmuntz (Bethesda, United States of America), M. Nicolls (Stanford, United States of America), . On Behalf Of Asco1 Investigators (- , United States of America)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension: results from the randomised controlled RACE study
X. Jais (Le Kremlin-Bicêtre, France), P. Brenot (Le Plessis robinson, France), H. Bouvaist (Grenoble, France), M. Canuet (Strasbourg, France), C. Chabanne (Rennes, France), A. Chaouat (Nancy, France), V. Cottin (Bron, France), P. De Groote (Lille, France), C. Dromer (Bordeaux, France), N. Favrolt (Dijon, France), C. Garcia Alonso (Le Plessis Robinson, France), B. Gérardin (Le Plessis Robinson, France), D. Horeau-Langlard (Nantes, France), M. Jevnikar (Le Kremlin-Bicêtre, France), P. Magro (Tours, France), D. Montani (Le Kremlin-Bicêtre, France), F. Parent (Le Kremlin-Bicêtre, France), C. Pison (Grenoble, France), G. Prévot (Toulouse, France), S. Renard (Marseille, France), L. Savale (Le Kremlin-Bicêtre, France), A. Simon (Poitiers, France), O. Sitbon (Le Kremlin-Bicêtre, France), R. Tresorier (Clermont-Ferrand, France), C. Tromeur (Brest, France), H. Agostini (Le Kremlin-Bicêtre, France), C. Piedvache (Le Kremlin-Bicêtre, France), E. Fadel (Le Plessis Robinson, France), M. Humbert (Le Kremlin-Bicêtre, France), G. Simonneau (Le Kremlin-Bicêtre, France)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - Transbronchial lung cryobiopsy for interstitial lung disease diagnosis: results of the COLDICE Study
L. Troy (Sydney, Australia), C. Grainge (Newcastle, Australia), T. Corte (Sydney, Australia), J. Williamson (Sydney, Australia), M. Vallely (Sydney, Australia), W. Cooper (Sydney, Australia), A. Mahar (Sydney, Australia), J. Myers (Michigan, United States of America), S. Lai (Sydney, Australia), E. Mulyadi (Sydney, Australia), P. Torzillo (Sydney, Australia), M. Phillips (Perth, Australia), H. Jo (Sydney, Australia), S. Webster (Sydney, Australia), Q. Lin (Sydney, Australia), J. Rhodes (Sydney, Australia), M. Salamonsen (Perth, Australia), J. Wrobel (Perth, Australia), B. Harris (Sydney, Australia), G. Don (Sydney, Australia), P. Wu (Sydney, Australia), B. Ng (Sydney, Australia), C. Oldmeadow (Newcastle, Australia), G. Raghu (Seattle, United States of America), E. Lau (Sydney, Australia), .. Coldice Investigators (Sydney, Australia)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Wrap-up by discussant and discussion
M. Kolb (Hamilton (ON), Canada)
No content made available
No content made available
Wrap-up by discussant and discussion
M. Kreuter (Heidelberg, Germany)
No content made available
No content made available